This is part of a continuing series describing antiviral antibodies to prevent and treat SARS-CoV-2 infections. In this series, we will discuss the fundamental nature of virus evolution, how ...
In a recent study posted to the bioRxiv* pre-print server, researchers in the United States described a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibody ...
The benefits of globalization have ushered in the reality of fast-spreading infectious diseases. This has made the quick development of preventive vaccines and immune therapies imperative. Spread of ...
In a recent study published in Science Translational Medicine, researchers evidenced that the S2 subunit of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) could be an integral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback